Soft‐tissue sarcomas (STS) are rare tumors that account for 1% of all adult malignancies,
with over 100 different histologic subtypes occurring predominately in the trunk, extremity …

Locoregional recurrence negatively impacts both long‐term survival and quality of life for
several malignancies. For appropriate‐risk patients with an isolated, resectable, local …

Background Retroperitoneal soft tissue sarcomas comprise a heterogeneous group of rare
tumors of mesenchymal origin that include several well-defined histologic subtypes. In 2015 …

Purpose This guideline provides evidence-based recommendations addressing the
indications for radiation therapy (RT), sequencing of local therapies, and appropriate dose …

Background Recruitment into clinical trials for retroperitoneal sarcoma has been
challenging, resulting in termination of the only randomised multicentre trial in the USA …

En la actualidad los profesionales de la salud son el recurso más valioso con el que cuenta
cada país para combatir la enfermedad COVID-19. Las tasas de contagio intrahospitalario …

Purpose To define the optimal initial management and the best extent of surgery that would
optimize margins on primary retroperitoneal sarcomas (RPS). Patients and Methods A total …

Background Retroperitoneal soft tissue sarcomas (RPS) are rare tumors that include several
well-defined histologic subtypes. Although surgery is the mainstay of curative therapy, no …

Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a
heterogenous mix of clinical and pathologic characteristics. STS can develop from fat …

Purpose Integration of numerous prognostic variables not included in the conventional
staging of retroperitoneal soft tissue sarcomas (RPS) is essential in providing effective …